Trial intelligence / Profile preview

Efficacy of a Novel Stannous Fluoride and Potassium Nitrate Dentifrice for Dentin Hypersensitivity

NCT07215767Phase 3Completed

Sponsor
Haleon
Start
Sep 2025
Primary completion
Aug 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of potassium nitrate + stannous fluoride in dentin hypersensitivity (DH), sponsored by Haleon. Started Sep 2025; status: completed.

02

Drugs

potassium nitrate + stannous fluoride
03

Conditions

dentin hypersensitivity (DH)

Beyond the preview

Go deeper on NCT07215767.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07215767.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call